Product Description
The global direct restorative material market was valued at nearly $2.5 billion in 2025. This is expected to increase over the forecast period at a CAGR of 4.0% to reach $3.3 billion in 2032.
The full report suite on the global market for direct restorative materials includes composite, glass ionomer (GI) and resin-modified GI (RMGI), as well as amalgam material segments. The number of direct restorative procedures is similarly divided into procedures performed with composite, GI/RMGI and amalgam. The units sold in the direct restorative material market are defined in millions of grams, while the ASP represents the cost of a single gram of a product.
The report includes data for 65 countries across 7 different regions which include North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Global Direct Restorative Material Market Trends
The direct restorative materials market demonstrates solid and sustained growth, driven by both increasing procedure volumes and continued value expansion. The segment remains one of the largest and most clinically essential categories within dental materials, supported by its routine use in restorative treatments. Market growth is primarily value-led, with stable unit demand complemented by gradual ASP improvement in advanced composite materials. North America and Latin America represent the largest revenue contributors, while Asia-Pacific and Central & Eastern Europe continue to gain share through expanding access to restorative care.
Global Direct Restorative Material Market Share Insights
- Solventum became the owner of the Filtek™ portfolio following the 2024 spin-off of 3M’s Health Care division, with the products transitioning to the Solventum brand while maintaining the same formulations and clinical performance characteristics. 3M’s signature composite material is the Filtek™ product line, which offers various products, ranging from nanohybrid to flowable composites. 3M has repeatedly introduced technological advancements to the science of dental composites. For instance, the nanotechnology used in Filtek™ Z250XT allows this material to reach the opalescence of natural tooth enamel. 3M has also historically supported the trend in improving the durability and longevity of composite restoratives.
- Dentsply Sirona was the second-leading competitor in the direct restorative material market in 2025. The company categorizes its composite products into universal, posterior, flowable and compomer composites. For each type of material, the company offers a variety of product lines, including products such as TPH®3 Micro Matrix universal composite and Ceram-X™ universal nanoceramic restorative, among other products. The company owns the patented granulated filler technology SphereTec™. This technology incorporates spheres of submicron glass to improve the handling comfort and aesthetic appeal while covering a full range of VITA shades for both posterior and anterior direct restorations.
- Kerr was the third-leading competitor in the global direct restorative material market in 2025. Its share largely stemmed from its success in the amalgam category. Kerr’s two main amalgam product lines, Tytin® and Contour™, comprised the bulk of the company’s amalgam sales, although the company also offered OptiMix® as an alloy alternative.
Global Direct Restorative Material Market Segmentation Summary
- Direct Restorative Material Market – Further Segmented Into:
- Product Type: Composite Resin, Glass Ionomer/Resin-Modified GI, Amalgam.
- Delivery Type: Powder/Liquid, Auto-Mix Syringe, Two-Paste/Syringe, Unit-Dose/Capsule.
- Curing Method: Light-Cure, Self-Cure, Dual- Cure.
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
